AU2003242506A1 - Tf antagonist - Google Patents
Tf antagonistInfo
- Publication number
- AU2003242506A1 AU2003242506A1 AU2003242506A AU2003242506A AU2003242506A1 AU 2003242506 A1 AU2003242506 A1 AU 2003242506A1 AU 2003242506 A AU2003242506 A AU 2003242506A AU 2003242506 A AU2003242506 A AU 2003242506A AU 2003242506 A1 AU2003242506 A1 AU 2003242506A1
- Authority
- AU
- Australia
- Prior art keywords
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201100 | 2002-07-12 | ||
DKPA200201100 | 2002-07-12 | ||
PCT/DK2003/000480 WO2004007557A2 (en) | 2002-07-12 | 2003-07-09 | Tf antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003242506A1 true AU2003242506A1 (en) | 2004-02-02 |
Family
ID=30011020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003242506A Abandoned AU2003242506A1 (en) | 2002-07-12 | 2003-07-09 | Tf antagonist |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003242506A1 (en) |
WO (1) | WO2004007557A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004064870A2 (en) * | 2003-01-22 | 2004-08-05 | Novo Nordisk A/S | Radiolabelled tissue factor binding agent and the use thereof |
WO2005025623A2 (en) * | 2003-07-28 | 2005-03-24 | Emory University | Ef-24-factor vii conjugates |
GB2419774A (en) | 2004-10-27 | 2006-05-03 | Ericsson Telefon Ab L M | Accessing IP multimedia subsystem (IMS) services |
UA109633C2 (en) | 2008-12-09 | 2015-09-25 | HUMAN ANTIBODY AGAINST TISSUE FACTOR | |
WO2011069149A2 (en) | 2009-12-04 | 2011-06-09 | Dcb-Usa Llc | Cathepsin s inhibitors |
CN111012921A (en) * | 2010-06-15 | 2020-04-17 | 根马布股份公司 | Human antibody drug conjugates against tissue factor |
ES2983564T3 (en) * | 2013-11-21 | 2024-10-23 | Genmab As | Lyophilized formulation of antibody-drug conjugate |
WO2017121436A1 (en) | 2016-01-15 | 2017-07-20 | Rigshospitalet | Quantitative pet imaging of tissue factor expression using 18f-labled active site inhibited factor vii |
MA46864A (en) * | 2016-11-17 | 2021-04-28 | Minerva Imaging Aps | FACTOR VII INHIBITED BY THE ACTIVE SITE MARKED BY 177-LU |
TWI841554B (en) | 2018-03-21 | 2024-05-11 | 丹麥商珍美寶股份有限公司 | Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate |
CA3099547A1 (en) | 2018-05-07 | 2019-11-14 | Reshma Abdulla RANGWALA | Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5788965A (en) * | 1991-02-28 | 1998-08-04 | Novo Nordisk A/S | Modified factor VII |
WO2000042973A2 (en) * | 1999-01-22 | 2000-07-27 | The Burnham Institute | Homing pro-apoptotic conjugates and methods of using same |
WO2001002439A1 (en) * | 1999-07-01 | 2001-01-11 | Yale University | Neovascular-targeted immunoconjugates |
AU7270600A (en) * | 1999-09-20 | 2001-04-24 | Novo Nordisk A/S | Bivalent inhibitor of fviia/tf/fxa complex |
JP2001213804A (en) * | 2000-01-31 | 2001-08-07 | Chugai Pharmaceut Co Ltd | Antitissue factor antibody complex |
-
2003
- 2003-07-09 AU AU2003242506A patent/AU2003242506A1/en not_active Abandoned
- 2003-07-09 WO PCT/DK2003/000480 patent/WO2004007557A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004007557A3 (en) | 2004-04-22 |
WO2004007557A2 (en) | 2004-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002951728A0 (en) | Component interlocking | |
AU2003224111A1 (en) | Substituted pyrazolo-pyrimidine-4-ones | |
AU2002335152A1 (en) | Robot-phone | |
AU2002952384A0 (en) | Structures | |
WO2003072535A8 (en) | Substituted hydroxyethylamines | |
AU2003238043A1 (en) | Substituted imidazotriazines | |
AU2003245984A1 (en) | Hetero-cyclicaly substituted imidazotriazines | |
AU2003230395A1 (en) | Micro-support structures | |
AU2003294900A1 (en) | Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides | |
AU2003242506A1 (en) | Tf antagonist | |
AU2003212366A1 (en) | Substituted 4-aminocyclohexanols | |
AU2003290818A1 (en) | Topoisomerase-targeting agents | |
AU2002367810A1 (en) | Bis-transition-metal-chelate-probes | |
AU2002368348A1 (en) | Electrosomatogram | |
AU2002318053A1 (en) | Suplier | |
AU2002348964A1 (en) | Snowbike | |
AU2002341221A1 (en) | Honey-brandy | |
AU2002344387A1 (en) | Multifunction-pillow | |
AU2002100031A4 (en) | earliPay | |
AU2002100482A4 (en) | Tail-gate-ezy | |
AU2002100498A4 (en) | Linline | |
AU2002100508A4 (en) | Photocard | |
AU2002100510A4 (en) | Bottlenecker | |
AU2002100541A4 (en) | Backmate | |
AU2002100602A4 (en) | Bonsystem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |